TMDX · TransMedics Group, Inc. · Debt
$65.99
-1.13 (-1.68%)
At close · Oct 30
Return incl. dividend (before tax)
Q1 2026 earnings call transcript
Market Cap
$2.29B
Shares
34.68M
Volume · Oct 30
900.11K
Avg daily vol (3M)
835.12K
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Read debt and covenant terms in your AI or your code through MCP and the API →Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-06-30 | USD 3,646,000 | 10-Q filed 2026-08-04 |
| Current portion of long-term debt | 2026-06-30 | USD 20,000,000 | 10-Q filed 2026-08-04 |
| Finance lease liabilities | 2026-06-30 | USD 347,660,000 | 10-Q filed 2026-08-04 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
| Noncurrent convertible debt | 2026-06-30 | USD 454,260,000 | 10-Q filed 2026-08-04 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 2,411,000 | 10-Q filed 2026-08-04 |
| Noncurrent other long-term debt | 2026-06-30 | USD 39,743,000 | 10-Q filed 2026-08-04 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1756262
CUSIP
89377M109
13F (30d)
121 filings
110 filers
Visit website
Investor relations